Seo et al., 2010 - Google Patents
Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammationSeo et al., 2010
View PDF- Document ID
- 16556697858093320578
- Author
- Seo J
- Jeon Y
- Lee Y
- Yoon G
- Won D
- Ha J
- Jeong S
- Lee S
- Ahn B
- Lee J
- Publication year
- Publication venue
- Journal of Nuclear Medicine
External Links
Snippet
The aim of this study was to investigate the feasibility of nuclear molecular imaging using the human sodium iodide symporter (hNIS) as a reporter gene to monitor macrophage migration toward the inflammatory foci. Methods: A stable macrophage cell line coexpressing hNIS …
- 210000002540 Macrophages 0 title abstract description 81
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Revealing the fate of transplanted stem cells in vivo with a novel optical imaging strategy | |
| Nedrow et al. | Imaging of programmed cell death ligand 1: impact of protein concentration on distribution of anti-PD-L1 SPECT agents in an immunocompetent murine model of melanoma | |
| Higuchi et al. | Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart | |
| Hyafil et al. | Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for PET | |
| Zhou et al. | In vivo detection of stem cells grafted in infarcted rat myocardium | |
| Koehne et al. | Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes | |
| Moroz et al. | Comparative analysis of T cell imaging with human nuclear reporter genes | |
| Majmudar et al. | Polymeric nanoparticle PET/MR imaging allows macrophage detection in atherosclerotic plaques | |
| Dobrenkov et al. | Monitoring the Efficacy of Adoptively Transferred Prostate Cancer–Targeted Human T Lymphocytes with PET and Bioluminescence Imaging | |
| Krebs et al. | Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes | |
| Fruhwirth et al. | A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments | |
| Fendler et al. | Establishing 177Lu-PSMA-617 radioligand therapy in a syngeneic model of murine prostate cancer | |
| Seo et al. | Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation | |
| Müller et al. | Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery | |
| Nie et al. | PET/MRI of hypoxic atherosclerosis using 64Cu-ATSM in a rabbit model | |
| Liu et al. | Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers | |
| Hoffmann et al. | Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer | |
| Luo et al. | PET imaging of VEGFR-2 expression in lung cancer with 64Cu-labeled ramucirumab | |
| Haddad et al. | A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer | |
| Shokeen et al. | Molecular Imaging of Very Late Antigen–4 (α4β1 Integrin) in the Premetastatic Niche | |
| Galli et al. | In vivo imaging of natural killer cell trafficking in tumors | |
| Iafrate et al. | How non-invasive in vivo cell tracking supports the development and translation of cancer immunotherapies | |
| Gholami et al. | Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer | |
| Minamimoto et al. | 4′-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non–Small Cell Lung Cancer | |
| Shaffer et al. | PET imaging of the natural killer cell activation receptor NKp30 |